CMOs and CDMOs must be flexible when dealing with unplanned disruptions.
FREMONT, CA: The supply chains of every company are unique. o cope with the next set of unforeseen disruptions, contract manufacturing organizations (CMOs) and contract development manufacturing organizations (CDMOs) must demonstrate high flexibility. The good news is that contract organizations can improve their supply chains today to enhance their flexibility and ability to adapt quickly when new challenges arise.
Various initiatives involving any of the following steps will support pharma contract manufacturers in realizing the benefits of flexibility. Still, no blanket approach enhances supply chain versatility for every organization.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Digitization: The ability to see and communicate your entire supply chain is essential to flexibility. In contrast, visibility and transparency can be eroded by disconnected systems that hinder pharma contract manufacturers from sharing data and collaborating with suppliers. Digital connectivity is essential to achieve end-to-end visibility. Pharma contract manufacturers can access and share up-to-date information about and with suppliers, establishing quality uniformity across the supplier ecosystem through specialized contract manufacturing software such as a quality management system (QMS) solution that offers supplier management functionality. Incorporating emerging technologies such as artificial intelligence (AI) into a modern supply chain QMS that integrates processes and digitally connects supplier data lays the foundation for even more advanced solutions. A growing number of pharma contract manufacturers can predict disruptions and streamline supplier management with the help of emerging technologies like artificial intelligence (AI). According to research experts, supply chain experts must put data at the center of their supply chain and apply Artificial Intelligence at scale to create a connected and truly intelligent supply chain.
Issues: Increasing supply chain visibility makes contract manufacturers more aware of the risks. In predictably unpredictable supply chains, change and new challenges are constants, so it is crucial for pharma contract manufacturers to continually assess the threats they face. According to your organization's business and regulatory requirements, stress testing, scenario planning, simulation models, and other proven approaches should be used accordingly.
Global events: Researchers recount how the expansion of contract manufacturers' supply chains across the globe seemed to continue for years, but policy changes and other world events sparked a reversal. As pharma supply chains have become more globalized in recent decades, industries have seen an increase in globalization. According to the policies of the three major trading blocs, researchers may be witnessing a countertrend towards regional and national self-reliance and a more localized supply chain. Researchers in the pharmaceutical industry have also noted that global supply chains are gradually shifting to local supply chains, requiring contract manufacturers to reevaluate their sourcing strategies. This reevaluation should be part of a broader initiative to mitigate risks and enhance flexibility.
More in News